https://www.pharma-marketing.com/astrazeneca-invests-2bn-in-summit-to-advance-adc-combinations/Pharma-Marketing.comen2026-10-01T12:49:03+00:00AstraZeneca invests $2bn in Summit to advance ADC combinations https://www.pharma-marketing.com/de/astrazeneca-investiert-2-milliarden-dollar-in-summit-und-plant-adc-kombinationen/Pharma-Marketing.comde2026-10-01T12:49:03+00:00AstraZeneca investiert 2 Milliarden Dollar in Summit und plant ADC-Kombinationen https://www.pharma-marketing.com/sanofi-and-regeneron-expand-immunology-alliance/Pharma-Marketing.comen2026-10-01T11:24:39+00:00Sanofi and Regeneron expand immunology alliance https://www.pharma-marketing.com/de/sanofi-und-regeneron-erweitern-immunologie-allianz/Pharma-Marketing.comde2026-10-01T11:24:38+00:00Sanofi und Regeneron erweitern Immunologie-Allianz https://www.pharma-marketing.com/dr-ulrike-banning-to-lead-medical-knowledge-solutions-at-vidal-mmi/Pharma-Marketing.comen2026-10-01T09:22:49+00:00Dr. Ulrike Banning to lead Medical Knowledge Solutions at Vidal MMI https://www.pharma-marketing.com/de/dr-ulrike-banning-leitet-medical-knowledge-solutions-bei-vidal-mmi/Pharma-Marketing.comde2026-10-01T09:22:48+00:00Dr. Ulrike Banning leitet Medical Knowledge Solutions bei Vidal MMI https://www.pharma-marketing.com/neovii-appoints-duncan-ferguson-as-chief-commercial-officer/Pharma-Marketing.comen2026-10-01T08:54:27+00:00Neovii appoints Duncan Ferguson as Chief Commercial Officer https://www.pharma-marketing.com/de/neovii-ernennt-duncan-ferguson-zum-chief-commercial-officer/Pharma-Marketing.comde2026-10-01T08:54:27+00:00Neovii ernennt Duncan Ferguson zum Chief Commercial Officer https://www.pharma-marketing.com/bionorica-ceo-prof-michael-popp-named-honorary-member-of-the-ga/Pharma-Marketing.comen2026-10-01T08:36:33+00:00Bionorica CEO Prof. Michael Popp named honorary member of the GA https://www.pharma-marketing.com/de/bionorica-ceo-prof-michael-popp-wird-ehrenmitglied-der-ga/Pharma-Marketing.comde2026-10-01T08:36:32+00:00Bionorica-CEO Prof. Michael Popp wird Ehrenmitglied der GA https://www.pharma-marketing.com/codis-appoints-steven-facer-as-chief-commercial-officer/Pharma-Marketing.comen2026-10-01T08:18:21+00:00Codis appoints Steven Facer as Chief Commercial Officer https://www.pharma-marketing.com/de/codis-ernennt-steven-facer-zum-chief-commercial-officer/Pharma-Marketing.comde2026-10-01T08:18:21+00:00Codis ernennt Steven Facer zum Chief Commercial Officer https://www.pharma-marketing.com/almirall-presents-new-dermatology-data-at-eadv-2026/Pharma-Marketing.comen2026-09-30T15:07:39+00:00Almirall presents new dermatology data at EADV 2026 https://www.pharma-marketing.com/de/almirall-stellt-neue-dermatologie-daten-auf-dem-eadv-2026-vor/Pharma-Marketing.comde2026-09-30T15:07:39+00:00Almirall stellt neue Dermatologie-Daten auf dem EADV 2026 vor https://www.pharma-marketing.com/trend-report-finds-broad-support-for-cannabis-therapy-but-stigma-persists/Pharma-Marketing.comen2026-09-30T14:36:31+00:00Trend report finds broad support for cannabis therapy, but stigma persists https://www.pharma-marketing.com/de/trend-report-sieht-breite-akzeptanz-fuer-cannabistherapie-aber-anhaltendes-stigma/Pharma-Marketing.comde2026-09-30T14:36:31+00:00Trend-Report sieht breite Akzeptanz für Cannabistherapie, aber anhaltendes Stigma https://www.pharma-marketing.com/nurix-achieves-7-million-milestone-in-pfizer-collaboration/Pharma-Marketing.comen2026-09-30T14:13:06+00:00Nurix Achieves $7 Million Milestone in Pfizer Collaboration https://www.pharma-marketing.com/de/nurix-erreicht-7-millionen-dollar-meilenstein-in-pfizer-kooperation/Pharma-Marketing.comde2026-09-30T14:13:06+00:00Nurix erreicht 7-Millionen-Dollar-Meilenstein in Pfizer-Kooperation https://www.pharma-marketing.com/alnylam-highlights-amvuttra-through-attr-cm-patient-story/Pharma-Marketing.comen2026-09-30T13:22:54+00:00Alnylam highlights Amvuttra through ATTR-CM patient story https://www.pharma-marketing.com/de/alnylam-rueckt-amvuttra-mit-patientengeschichte-zu-attr-cm-in-den-fokus/Pharma-Marketing.comde2026-09-30T13:22:54+00:00Alnylam rückt Amvuttra mit Patientengeschichte zu ATTR-CM in den Fokus https://www.pharma-marketing.com/kbv-launches-vaccination-campaign-for-medical-practices/Pharma-Marketing.comen2026-09-30T13:16:17+00:00KBV launches vaccination campaign for medical practices https://www.pharma-marketing.com/de/kbv-startet-impfkampagne-fuer-arztpraxen/Pharma-Marketing.comde2026-09-30T13:16:17+00:00KBV startet Impfkampagne für Arztpraxen https://www.pharma-marketing.com/grunenthal-places-e850-million-bond-financing/Pharma-Marketing.comen2026-09-30T13:00:49+00:00Grünenthal places €850 million bond financing https://www.pharma-marketing.com/de/gruenenthal-platziert-anleihe-ueber-850-millionen-euro/Pharma-Marketing.comde2026-09-30T13:00:49+00:00Grünenthal platziert Anleihe über 850 Millionen Euro https://www.pharma-marketing.com/pharming-announces-ceo-transition/Pharma-Marketing.comen2026-09-30T12:45:29+00:00Pharming announces CEO transition https://www.pharma-marketing.com/de/pharming-kuendigt-ceo-wechsel-an/Pharma-Marketing.comde2026-09-30T12:45:29+00:00Pharming kündigt CEO-Wechsel an https://www.pharma-marketing.com/abbvie-teams-up-with-valkai-on-ai-for-clinical-development/Pharma-Marketing.comen2026-09-30T12:35:33+00:00AbbVie teams up with Valkai on AI for clinical development https://www.pharma-marketing.com/de/abbvie-kooperiert-mit-valkai-bei-ki-in-der-klinischen-entwicklung/Pharma-Marketing.comde2026-09-30T12:35:32+00:00AbbVie kooperiert mit Valkai bei KI in der klinischen Entwicklung